Here's the ISRCTN registry entry for MAGENTA - https://www.isrctn.com/ISRCTN23962803
I can't find anything registered in ISRCTN. I guess that's a good thing? :/ eta: But then, there's always FITNET......
Presumably that's why GET has morphed into GAT etc?
Magenta was in progress between 2015 and 2018 (recruitment closed in March 2018).
The study page is here: https://www.rcpch.ac.uk/work-we-do/bpsu/study-severe-chronic-fatigue-syndrome-myalgic-encephalitis-cfsme just looking at...
All the ethics approval letters are also here:...
Here are the descriptions of the therapies from the supplementary material provided with the 2019 protocol paper:...
It feels like we've been waiting for this trial for at least a decade... (2015ish?). Anyway. I thought it might be useful to tie together a few...
I wasn't suggesting saying the opposite... (although if there is persistent/reactivated virus then antivirals may well be helpful to some). It...
Likely it's to conserve energy. Fighting against organisms that are trying to hijack your cells to their own ends is an energy intense enterprise....
Just seen this Science article about it:...
Also, their FB page: https://www.facebook.com/Channel4News There is also an address and phone number:...
It looks like something has gone seriously awry with the reference citations. Todd has also spotted it. [MEDIA] I suspect he'll have more to...
Looks like Gez has found it... [MEDIA] ...so I did a bit of a google of Janet's therapy company... [ATTACH]
Just had an update email:...
Just had an email update:...
Update: I've done something. I wrote to Springer Nature Research Integrity dept, and they are going to look into it.
Just to add: One of the Editors in Chief of the journal - Signal Transduction and Targeted Therapy - is Prof Yu-Quan Wei, who is at the same...
Reminder that the deadline for the normal online survey is today (4 Oct) at 11.59pm...
Hmmm... methinks Fauci is trying to rewrite history somewhat. Or maybe, not so much rewrite, but establish it - as it is very difficult to find...
Separate names with a comma.